| Literature DB >> 35317333 |
Toni Luise Meister1, Yannick Brüggemann1, Barbora Tamele2, John Howes2, Eike Steinmann1, Daniel Todt1,3.
Abstract
Transmission via fomites poses a major dissemination route for many human pathogens, particularly because of transfer via fingertips. Here, we present a protocol to investigate direct transfer of infectious agents from fomites to humans via naked fingertips. The protocol is suitable for pathogens requiring highest biosafety levels (e.g., SARS-CoV-2). We used an artificial skin to touch a defined volume of virus suspension and subsequent quantification of infectious entities allows quantitative measurement of transfer efficiency and risk assessment. For complete information on the generation and use of this manuscript, please refer to Todt et al. (2021).Entities:
Keywords: Biotechnology and bioengineering; Cell Biology; Cell culture; Health Sciences; Immunology; Material sciences; Microbiology
Mesh:
Year: 2022 PMID: 35317333 PMCID: PMC8932683 DOI: 10.1016/j.xpro.2022.101188
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1A method to determine transmission of SARS-CoV-2 via artificial skin in a BSL3 laboratory
(A) Each surface to be investigated is contaminated with 5 drops of 10 μL virus suspension. The virus suspension can either be directly subjected to the following steps or after desiccation.
(B) Hereafter, the hydrated VITRO Skin® is fixed in the provided gray frame.
(C) To recover residual infectious virus from the respective fomite, the index finger is put on the unruffled site of the VITRO Skin® and subsequently printed on the fomite for 5 s or rubbed across once.
(D and E) The VITRO Skin® is then unhinged from the frame, transferred into a container filled with 2 mL DMEM w/o FCS and vortexed for 1 min.
(F) To calculate the amount of infectious virus being recovered, an end-point-dilution assay is performed. Therefore, the medium from the first row of the seeded cells is discarded, 222 μL of the vortexed sample is added to each well and is serially dilute by thorough mixing and subsequently transferring 22 μL into the next row.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| SARS-CoV-2 (hCoV-19/Germany/BY-Bochum-1/2020) | In house | GISAID: EPI_ISL_1118929 |
| Crystal Violet | Sigma-Aldrich | CAT#1.01408 |
| Methanol | Carl Roth GmbH + Co. KG | CAT#X948.2 |
| Ethanol | Carl Roth GmbH + Co. KG | CAT#9065.1 |
| Dulbecco’s modified Eagle’s medium | Thermo Fisher Scientific | CAT#11965092 |
| Penicillin/streptomycin | Thermo Fisher Scientific | CAT#15070063 |
| L-Glutamine | Thermo Fisher Scientific | CAT#A2916801 |
| Non-essential amino acids | Thermo Fisher Scientific | CAT#11140050 |
| Fetal calf serum | Thermo Fisher Scientific | CAT#10270106 |
| Amphotericin B | Thermo Fisher Scientific | CAT#15290026 |
| Bovine serum albumin, fraction V | Sigma-Aldrich | CAT#CA-2153 |
| VeroE6 | C. Drosten und M. Müller | N/A |
| GraphPad Prism version 9.1.1 for Windows | GraphPad Software | N/A |
| Excel 2019 | Microsoft Corporation | N/A |
| Stainless steel carrier | GK-Formblech | CAT#10000-3021 |
| 25 mL Container | Sarstedt | CAT#60.9922.115 |
| VITRO Skin® N-19 Starter Kit (critical reagent) | IMS | N/A |